09 Jan 2019

ENDOLOGIX RECALLS NELLIX SYSTEM FOR PATIENT SAFETY

Endologix Inc., a developer and marketer of treatments for aortic disorders, has stopped unrestricted sales and use of the Nellix System in order to ensure optimal outcomes for patients. The existing inventory will be voluntarily recalled as described in a Field Safety Notification (FSN) issued in January. The Nellix System

0
03 Apr 2018

APRIL VTN REPORT

  Vein Therapy News    Industry Report     CIGNA PURCHASING EXPRESS SCRIPTS FOR $67B ON HEELS OF CVS-AETNA VERTICAL MERGER Cigna, which failed in an attempt to merge with Anthem last year, is now going to purchase Express Scripts, the country’s largest pharmacy benefit management (PBM) firm, for $67 billion. Cigna

0